PRTN3 and arthritic joint disease: Given the cross-reactivity of ACPA and their capability to bind a large number of citrullinated proteins, along with the fact that the exact location of target antigens in RA is largely unknown, and the limitations of animal models of arthritis, we are still far from solid conclusions in this regard [70].